Show simple item record

dc.contributor.authorGartland, Alison
dc.contributor.authorMason-Savas, April
dc.contributor.authorYang, Meilheng
dc.contributor.authorMacKay, Carole A.
dc.contributor.authorBirnbaum, Mark J.
dc.contributor.authorOdgren, Paul R.
dc.date2022-08-11T08:10:07.000
dc.date.accessioned2022-08-23T16:56:11Z
dc.date.available2022-08-23T16:56:11Z
dc.date.issued2009-11-07
dc.date.submitted2011-02-16
dc.identifier.citationAm J Pathol. 2009 Dec;175(6):2668-75. Epub 2009 Nov 5. <a href="http://dx.doi.org/10.2353/ajpath.2009.090185">Link to article on publisher's site</a>
dc.identifier.issn0002-9440 (Linking)
dc.identifier.doi10.2353/ajpath.2009.090185
dc.identifier.pmid19893052
dc.identifier.urihttp://hdl.handle.net/20.500.14038/42874
dc.description.abstractThe septoclast is a specialized, cathepsin B-rich, perivascular cell type that accompanies invading capillaries on the metaphyseal side of the growth plate during endochondral bone growth. The putative role of septoclasts is to break down the terminal transverse septum of growth plate cartilage and permit capillaries to bud into the lower hypertrophic zone. This process fails in osteoclast-deficient, osteopetrotic animal models, resulting in a progressive growth plate dysplasia. The toothless rat is severely osteopetrotic because of a frameshift mutation in the colony-stimulating factor-1 (CSF-1) gene (Csf1(tl)). Whereas CSF-1 injections quickly restore endosteal osteoclast populations, they do not improve the chondrodysplasia. We therefore investigated septoclast populations in Csf1(tl)/Csf1(tl) rats and wild-type littermates, with and without CSF-1 treatment, at 2 weeks, before the dysplasia is pronounced, and at 4 weeks, by which time it is severe. Tibial sections were immunolabeled for cathepsin B and septoclasts were counted. Csf1(tl)/Csf1(tl) mutants had significant reductions in septoclasts at both times, although they were more pronounced at 4 weeks. CSF-1 injections increased counts in wild-type and mutant animals at both times, restoring mutants to normal levels at 2 weeks. In all of the mutants, septoclasts seemed misoriented and had abnormal ultrastructure. We conclude that CSF-1 promotes angiogenesis at the chondroosseous junction, but that, in Csf1(tl)/Csf1(tl) rats, septoclasts are unable to direct their degradative activity appropriately, implying a capillary guidance role for locally supplied CSF-1.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=19893052&dopt=Abstract">Link to Article in PubMed</a>
dc.relation.urlhttp://dx.doi.org/10.2353/ajpath.2009.090185
dc.subjectAnimals
dc.subjectBone Development
dc.subjectBone Diseases, Developmental
dc.subjectCartilage
dc.subjectChondrocytes
dc.subjectGrowth Plate
dc.subjectImmunohistochemistry
dc.subjectMacrophage Colony-Stimulating Factor
dc.subjectNeovascularization, Physiologic
dc.subjectOsteopetrosis
dc.subjectRats
dc.subjectRats, Mutant Strains
dc.subjectCell Biology
dc.titleSeptoclast deficiency accompanies postnatal growth plate chondrodysplasia in the toothless (tl) osteopetrotic, colony-stimulating factor-1 (CSF-1)-deficient rat and is partially responsive to CSF-1 injections
dc.typeJournal Article
dc.source.journaltitleThe American journal of pathology
dc.source.volume175
dc.source.issue6
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/odgren/3
dc.identifier.contextkey1789898
html.description.abstract<p>The septoclast is a specialized, cathepsin B-rich, perivascular cell type that accompanies invading capillaries on the metaphyseal side of the growth plate during endochondral bone growth. The putative role of septoclasts is to break down the terminal transverse septum of growth plate cartilage and permit capillaries to bud into the lower hypertrophic zone. This process fails in osteoclast-deficient, osteopetrotic animal models, resulting in a progressive growth plate dysplasia. The toothless rat is severely osteopetrotic because of a frameshift mutation in the colony-stimulating factor-1 (CSF-1) gene (Csf1(tl)). Whereas CSF-1 injections quickly restore endosteal osteoclast populations, they do not improve the chondrodysplasia. We therefore investigated septoclast populations in Csf1(tl)/Csf1(tl) rats and wild-type littermates, with and without CSF-1 treatment, at 2 weeks, before the dysplasia is pronounced, and at 4 weeks, by which time it is severe. Tibial sections were immunolabeled for cathepsin B and septoclasts were counted. Csf1(tl)/Csf1(tl) mutants had significant reductions in septoclasts at both times, although they were more pronounced at 4 weeks. CSF-1 injections increased counts in wild-type and mutant animals at both times, restoring mutants to normal levels at 2 weeks. In all of the mutants, septoclasts seemed misoriented and had abnormal ultrastructure. We conclude that CSF-1 promotes angiogenesis at the chondroosseous junction, but that, in Csf1(tl)/Csf1(tl) rats, septoclasts are unable to direct their degradative activity appropriately, implying a capillary guidance role for locally supplied CSF-1.</p>
dc.identifier.submissionpathodgren/3
dc.contributor.departmentDepartment of Orthopedics and Physical Rehabilitation
dc.contributor.departmentDepartment of Cell Biology
dc.source.pages2668-75


This item appears in the following Collection(s)

Show simple item record